CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-02 | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Sale 10b5-1 | −897 | $46.95 | $42K | 75,997 |
| 2025-03-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −2,037 | $55.24 | $113K | 77,365 |
| 2025-03-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,085 | $56.62 | $61K | 76,280 |
| 2025-03-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −3,340 | $57.67 | $193K | 72,940 |
| 2025-03-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −300 | $58.31 | $17K | 72,640 |
| 2025-03-14 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −4,458 | $55.19 | $246K | 79,402 |
| 2025-03-13 | Okey Stephanie Director | Sale | −5,000 | $54.00 | $270K | 8,867 |
| 2025-03-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +13,126 | $33.02 | $433K | 117,027 |
| 2025-03-12 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −13,126 | $53.31 | $700K | 103,901 |
| 2025-03-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,395 | $33.02 | $79K | 106,296 |
| 2025-03-12 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −2,395 | $53.23 | $127K | 103,901 |
| 2025-03-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,126 | 0 | ||
| 2025-03-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,395 | 0 | ||
| 2025-03-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +5,662 | $33.02 | $187K | 109,563 |
| 2025-03-11 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −5,662 | $53.02 | $300K | 103,901 |
| 2025-03-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +1,719 | $33.02 | $57K | 105,620 |
| 2025-03-11 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,719 | $53.01 | $91K | 103,901 |
| 2025-03-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,662 | 13,126 | ||
| 2025-03-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,719 | 2,395 | ||
| 2025-03-10 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +45,392 | $33.02 | $1.5M | 149,293 |
Page 26 of 41 · 804 trades